Share this article:
Spectrum Pharmaceuticals' neutropenia treatment, Rolontis

Spectrum Pharmaceuticals' neutropenia treatment, Rolontis

Get the latest OC business updates for FREE

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI), a clinical-stage biopharmaceutical company focusing on oncology drug development, announced Jan. 4 a $20 million equity investment by South Korean pharmaceutical company Hanmi Pharmaceutical ...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to OCBJ.com archives
  • Book of Lists — the most comprehensive business resource in Orange County
  • NEW: Orange County 500 — influential business leaders you need to know
Yours for only $99

For digital licensing requests for this article, Contact Kim Lopez